Cartilaginous features in matrix-producing carcinoma of the breast: Four cases report with histochemical and immunohistochemical analysis of matrix molecules

Modern Pathology

Volumn 21, Issue 10, 2008, Pages 1282-1292

  Kusafuka, Kimihide ^a   Muramatsu, Koji ^a   Kasami, Masako ^a   Kuriki, Ken ^b   Hirobe, Kumiko ^a   Hayashi, Isamu ^a   Watanabe, Hideto ^c   Hiraki, Yuji ^d   Shukunami, Chisa ^d   Mochizuki, Toru ^a   Kameya, Toru ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b University of Tokyo   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d Kyoto University   (Japan)

Author keywords

Aggrecan; Breast; Collagens; Electron microscopy; Immunohistochemistry; Matrix producing carcinoma

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 4; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; MATRIX PROTEIN; PROTEIN P63; TRANSCRIPTION FACTOR SOX9;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CARTILAGE; CARTILAGE CELL; CARTILAGINOUS TISSUE; CASE REPORT; CELL DIFFERENTIATION; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; STROMA CELL; TUMOR CELL;

ADENOCARCINOMA; AGGRECANS; BREAST NEOPLASMS; COLLAGEN TYPE I; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; FATAL OUTCOME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 52549112368     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.120     Document Type: Article

References (26)

1. Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma: metaplastic carcinoma. In: Tvassolli FA, Devilee P (eds). Pathology and Genetics: Tumours of the Breast and Female Genital Organs. IARC Press: Lyon, France, 2003, pp 37-41.
2. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 1988;20:623-635.
3. Luo W, Guo C, Zhang J, et al. Aggrecan from start to finish. J Bone Miner Metab 2000;18:51-56.
4. Kusafuka K, Hiraki Y, Shukunami C, et al. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissue in vivo: relationship with angiogenic factors in the cartilage. Acta Histochem 2002;104:167-175.
5. Zhao M, Takata T, Orawa I, et al. Immunohistochemical evaluation of the small and large proteoglycans in pleomorphic adenoma of the salivary glands. J Oral Pathol Med 1999;28:37-42.
6. Kusafuka K, Hiraki Y, Shukunami C, et al. Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis. Am J Pathol 2001;158:1465-1472.
7. Hiraki Y, Tanaka H, Inoue H, et al. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun 1991;175:971-977.
8. Hiraki Y, Mutsui K, Endo N, et al. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur J Biochem 1999;260:869-878.
9. Ng LJ, Wheatley S, Muscat GEO, et al. Sox9 binds DNA, activates transcription, and coexpression with type II collagen during chondrogenesis in the mouse. Dev Biol 1997;183:108-121.
10. Lefebvre V, Huang W, Harley VR, et al. Sox9 is a potent activator of the chondrocyte-specific enhancer of the proá1(II) collagen gene. Mol Cell Biol 1997;17:2336-2346.
11. Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat Genet 1999;22:85-89.
12. Wehrli BM, Haung W, De Crombrugghe B, Ayala AG, Czerniak B. 'Sox9', a master regulator of chodrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 2003;34:263-269.
13. Allen AC. So-called mixed tumors of the mammary gland of dog and man, with special reference to the general problem of cartilage and bone formation. Arch Pathol Lab Med 1940;29:589-624.
14. Murad TM, von Hamm E. Ultrastructure of myoepithelial cells in human mammary gland tumors. Cancer 1968;21:1137-1149.
15. Meryem MK, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506-1512.
16. Morinaga S, Nakajima T, Shimosato Y. Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study. Hum Pathol 1987;8:1218-1226.
17. Weber A, Langhanki L, Schutz A, et al. Expression profile of p53, p63, and p73 in benign salivary gland tumors. Virchows Archiv 2002;441:428-436.
18. Milanezi F, Pereira EM, Ferreira FV, et al. CD99/MIC2 surface protein expression in breast carcinomas. Histopathology 2001;39:578-583.
19. Kim JH, Do HJ, Yang HM, et al. Overexpression of SOX9 in mouse embryonic stem cells directs the immediate chondrogenic commitment. Exp Mol Med 2005;31:261-268.
20. Kolettas E, Muir HI, Barrett JC, et al. Chondrocyte phenotype and cell survival are regulated by cultured conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology 2001;40:1146-1156.
21. Weiss AP, Dofman HD. S-100 protein in human cartilage lesion. J Bone Joint Surg Am 1986;68:521-526.
22. Landini G. Immunohistochemical demonstration of type II collagen in the chondroid tissue of pleomorphic adenomas of the salivary glands. Acta Pathol Jpn 1991;41:270-276.
23. Linsenmayer TF. Collagens. In: Hay ED (ed). Cell Biology of Extracellular Matrix, 2nd edn. Plenum: New York, 1991, pp 7-44.
24. Visscher DW, Sarkar FH, Sakr W, et al. Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study. Pathol Res Pract 1993;189:867-872.
25. Cheng J, Saku T, Okabe H, et al. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer 1992;69:2631-2640.
26. Saku T, Cheng J, Okabe H, et al. Immunolocalization of basement membrane molecules in the stroma of salivary pleomorphic adenoma. J Oral Pathol Med 1990;19:208-214.